Heparanase, heparin and the coagulation system in cancer progression (Q37006624)

17 August 2017

1 reference

title

Heparanase, heparin and the coagulation system in cancer progression (English)

1 reference

17 August 2017

1 reference

4

Benjamin Brenner

1 reference

17 August 2017

Israel Vlodavsky

1

1 reference

17 August 2017

Neta Ilan

2

1 reference

17 August 2017

Yona Nadir

3

1 reference

17 August 2017

Ben-Zion Katz

5

1 reference

17 August 2017

Annamaria Naggi

6

1 reference

17 August 2017

Giangiacomo Torri

7

1 reference

17 August 2017

Benito Casu

8

1 reference

17 August 2017

Ram Sasisekharan

9

1 reference

17 August 2017

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

120 Suppl 2

1 reference

17 August 2017

S112-20

1 reference

Functions of cell surface heparan sulfate proteoglycans

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Matrix proteoglycans: from molecular design to cellular function

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Roles of heparan-sulphate glycosaminoglycans in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparanase: a target for drug discovery in cancer and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heterodimer formation is essential for heparanase enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Mechanism of activation of human heparanase investigated by protein engineering.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Identification of active-site residues of the pro-metastatic endoglycosidase heparanase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparanase as a molecular target of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparanase as mediator of angiogenesis: mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparanase induces endothelial cell migration via protein kinase B/Akt activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

An ELISA method for the detection and quantification of human heparanase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparanase mediates cell adhesion independent of its enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparanase induces tissue factor expression in vascular endothelial and cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Prognosis of Cancers Associated with Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Tissue factor-factor VIIa signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Tissue factor, thrombin, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Induction of tissue factor expression in human monocytic cells by protease inhibitors through activating activator protein-1 (AP-1) with phosphorylation of Jun-N-terminal kinase and p38.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970139-1

7 January 2021

10.1016/S0049-3848(07)70139-1

Identifiers

DOI

1 reference

17 August 2017

1 reference